Frida Abel

1.0k total citations
27 papers, 736 citations indexed

About

Frida Abel is a scholar working on Neurology, Cancer Research and Molecular Biology. According to data from OpenAlex, Frida Abel has authored 27 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 15 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Frida Abel's work include Neuroblastoma Research and Treatments (20 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Adrenal and Paraganglionic Tumors (6 papers). Frida Abel is often cited by papers focused on Neuroblastoma Research and Treatments (20 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Adrenal and Paraganglionic Tumors (6 papers). Frida Abel collaborates with scholars based in Sweden, United States and Australia. Frida Abel's co-authors include Tommy Martinsson, Per Kogner, Helena Carén, Katarina Ejeskär, Cecilia Krona, Staffan Nilsson, Rose‐Marie Sjöberg, Andreas Muth, Ola Nilsson and Bo Wängberg and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Frida Abel

26 papers receiving 725 citations

Peers

Countries citing papers authored by Frida Abel

Since Specialization

Citations

This map shows the geographic impact of Frida Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frida Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frida Abel more than expected).

Fields of papers citing papers by Frida Abel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frida Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frida Abel. The network helps show where Frida Abel may publish in the future.

Co-authorship network of co-authors of Frida Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Frida Abel. A scholar is included among the top collaborators of Frida Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frida Abel. Frida Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis 2024 ·The Oncologist ·(unknown), (unknown), Thomas Olsson Bontell, Tomas Sjöberg Bexelius, (unknown), (unknown), (unknown), Jonas A. Nilsson, Helena Carén, Helena Mörse, Frida Abel	0
2	Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Mercedes Robledo, (unknown), Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin	2
3	NovelTPR::ROS1Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma 2022 ·Cancer Genomics & Proteomics ·(unknown), (unknown), Thomas Olsson Bontell, Henrik Fagman, Helene Sjögren, Anders E. Lind, Helena Carén, Magnus Tisell, Jonas A. Nilsson, Katarina Ejeskär, Magnus Sabel, Frida Abel	7
4	Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib 2021 ·Cancer Biology & Therapy ·(unknown), (unknown), Thomas Olsson Bontell, Helene Sjögren, Henrik Fagman, Ingrid Øra, (unknown), Magnus Tisell, Jonas A. Nilsson, Katarina Ejeskär, Magnus Sabel, Frida Abel	8
5	MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression 2020 ·PLoS Genetics ·Tajana Tešan Tomić, (unknown), (unknown), (unknown), Andreas Muth, Katarina Ejeskär, Staffan Nilsson, Erik Kristiansson, (unknown), Frida Abel	17
6	A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma 2017 ·PLoS ONE ·Tajana Tešan Tomić, (unknown), (unknown), Magnus Sabel, Katarina Truvé, Helene Sjögren, Sándor Dósa, Magnus Tisell, Birgitta Lannering, Fredrik Enlund, Tommy Martinsson, Pierre Åman, Frida Abel	25
7	Expression of TWEAK/Fn14 in neuroblastoma: Implications in tumorigenesis 2013 ·International Journal of Oncology ·Ingvild Pettersen, Ninib Baryawno, Frida Abel, (unknown), Svetlana N. Zykova, Jan‐Olof Winberg, Ugo Moens, Agnes Rasmuson, Per Kogner, John Inge Johnsen, Baldur Sveinbjørnsson	19
8	ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours 2013 ·Molecular Cancer ·(unknown), Cecilia Krona, Baldur Sveinbjørnsson, Erik Kristiansson, Daniel Dalevi, Ingrid Øra, Katleen De Preter, Raymond L. Stallings, John M. Maris, Rogier Versteeg, Staffan Nilsson, Per Kogner, Frida Abel	15
9	Stage-dependent expression of PI3K/Akt-pathway genes in neuroblastoma 2012 ·International Journal of Oncology ·Susanne Fransson, Frida Abel, Per Kogner, Tommy Martinsson, Katarina Ejeskär	21
10	A 6-gene signature identifies four molecular subgroups of neuroblastoma 2011 ·Cancer Cell International ·Frida Abel, Daniel Dalevi, Maria Nethander, Rebecka Jörnsten, Katleen De Preter, Joëlle Vermeulen, (unknown), Per Kogner, John M. Maris, Staffan Nilsson	25
11	Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes 2009 ·BMC Medical Genomics ·Kaisa Thorell, Annika Bergman, Helena Carén, Staffan Nilsson, Per Kogner, Tommy Martinsson, Frida Abel	22
12	High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours 2008 ·Biochemical Journal ·Helena Carén, Frida Abel, Per Kogner, Tommy Martinsson	202
13	Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer 2008 ·BMC Cancer ·Elin Karlsson, Ulla Delle, Anna Danielsson, Björn Olsson, Frida Abel, Per Karlsson, Khalil Helou	30
14	Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology 2005 ·European Journal of Cancer ·Frida Abel, Rose‐Marie Sjöberg, Staffan Nilsson, Per Kogner, Tommy Martinsson	28
15	A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours 2004 ·British Journal of Cancer ·Cecilia Krona, Katarina Ejeskär, Helena Carén, Frida Abel, (unknown), Tommy Martinsson	14
16	Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma 2004 ·British Journal of Cancer ·Dewi Astuti, Mark R. Morris, Cecilia Krona, Frida Abel, Dean Gentle, Tommy Martinsson, Per Kogner, Hartmut P.H. Neumann, Raimo Voutilainen, Charis Eng, Pierre Rustin, Farida Latif, Eamonn R. Maher	37
17	Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2 2003 ·Oncogene ·Cecilia Krona, Katarina Ejeskär, Frida Abel, Per Kogner, (unknown), (unknown), Rose‐Marie Sjöberg, Tommy Martinsson	45
18	Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours 2002 ·British Journal of Cancer ·Frida Abel, (unknown), Katarina Ejeskär, Cecilia Krona, Tommy Martinsson	33
19	Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors 2000 ·Cytogenetic and Genome Research ·Katarina Ejeskär, Frida Abel, (unknown), J.R. Backstrom, Per Kogner, Tommy Martinsson	28
20	Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24 1999 ·British Journal of Cancer ·Frida Abel, Katarina Ejeskär, Per Kogner, Tommy Martinsson	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact